WCN26-5461 ORAL IPTACOPAN THERAPY IN C3 GLOMERULOPATHY SHOWS CONSISTENT STABILIZATION OF eGFR SLOPE ACROSS PATIENT SUBGROUPS
David J. Kavanagh, Andrew S. Bomback, C. Nester, Robert M. Smith, Liz Lightstone, Marina Vivarelli, Sophie Chauvet, Ming‐Hui Zhao, Aiko PJ de Vries, Jean Grisouard, David Lawrence, Anna Aldea, Olivier Somenzi, Giuseppe Remuzzi (2026). WCN26-5461 ORAL IPTACOPAN THERAPY IN C3 GLOMERULOPATHY SHOWS CONSISTENT STABILIZATION OF eGFR SLOPE ACROSS PATIENT SUBGROUPS. , 11(4), DOI: https://doi.org/10.1016/j.ekir.2026.105746.
